0001554795-13-000649.txt : 20131101 0001554795-13-000649.hdr.sgml : 20131101 20131101164016 ACCESSION NUMBER: 0001554795-13-000649 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131031 FILED AS OF DATE: 20131101 DATE AS OF CHANGE: 20131101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER MARK CENTRAL INDEX KEY: 0001229529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 131186477 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J2G2 4 1 gnbt103113form4fletcher.xml FORM 4 X0306 4 2013-10-31 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001229529 FLETCHER MARK 555 RICHMOND ST. W, SUITE 604 TORONTO A6 M5V3B1 ONTARIO, CANADA 1 1 0 0 President and CEO Common Stock Purchase Option (right to buy) 0.001 2013-10-31 4 A 0 2254640 0 A 2014-01-01 2018-10-31 Common Stock 2254640 2254640 D On October 31, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 2,254,640 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective October 31, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan (1,854,640 options) and the 2001 stock plan (400,000 options). /s/ Mark A. Fletcher 2013-11-01